Name: Biotech & Life Sciences Global Venture Congress 2005 Date: August 25, & 26, 2005 Location: Madison Square Garden, New York, New York Conference website: http://bio.saeclub.com Contact email: bios at saeclub.com Nobel Laureate Dr. Eric Chivian, Keynote Speaker Nobel Laureate Dr. Eric Chivian, Director, Center for Health and the Global Environment, Harvard Medical School, will address the plenary session. More than 25, top-tier Biotech & Life Science VC's, who are actively investing will address various issues during panel discussions over the two days. A two-days conference designed to address the venture capital landscape, identify current trends in innovation, learn key technologies and scientific discoveries and discover emerging Biotech and Life Sciences companies. Attendees will be venture capitalists, angel investors, corporate investors, strategic investors, institutional investors, investment bankers, commercial bankers, biotech and life sciences company executives, entrepreneurs, analysts, scientists, researchers, academicians, strategic partners, and service providers. Exhibitor & Presentation Opportunities: Applications will be considered on a first-come-first basis for both the exhibitor and presentation opportunities available at the conference. See website for detail. Companies Seeking Funding: Apply at the earliest to be considered for presenting your company in front of renowned Biotech & Life Sciences investors. Representative Speakers: (see website for updates and more) Nobel Laureate Dr. Eric Chivian, M.D.,Director, Center for Health and the Global Environment, Harvard Medical School; A. Dana Callow, Jr.,Managing General Partner, Boston Millennia Partners; Maxine Gowen, Ph.D., Managing Partner, SR One; Jesse I. Treu, Ph.D , General Partner, Domain Associates; Gyan Parida, Ph.D., President/CEO, SAEC Ventures, Steven St. Peter, M.D., Partner,MPM Capital; Muz Mansuri, Ph.D., General Partner, Flagship Ventures; Elaine V. Jones, Ph.D., General Partner, Euclid SR Partners; Arthur Klausner, Venture Partner, A.M. Pappas & Associates; Lorenzo Pellegrini, Ph.D., Partner, Care Capital; David Milne, General Partner, Schroder Venture Life Sciences, John H. Friedman, Managing Partner, Easton Capital; Geoffrey W. Smith, Managing Partner, Ascent Biomedical Ventures, Mike Kaswan, Managing Director, KBL Healthcare Ventures; Philippe Chambon, Ph.D., M.D., General Partner, The Sprout Group -------------- next part -------------- An HTML attachment was scrubbed... URL: http://bioinformatics.org/pipermail/biodarwin/attachments/20050601/f6187459/attachment.html